General MedicationsNASALGeneric
NASCOBAL
CYANOCOBALAMIN
Standard Dose
0.5MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NASCOBAL is listed in Drugs@FDA under application 019722 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CYANOCOBALAMIN Form and strength GEL, METERED;NASAL - 0.5MG/INH Sponsor ENDO OPERATIONS Submission history Latest submission status date: 2003-08-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview NASCOBAL is listed in Drugs@FDA under application 019722 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYANOCOBALAMIN Form and strength GEL, METERED;NASAL - 0.5MG/INH Sponsor ENDO OPERATIONS Submission history Latest submission status date: 2003-08-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.